An open-label, randomized phase III study of early switch maintenance vs delayed second-line nivolumab in advanced stage squamous non-small cell lung cancer (NSCLC) patients after standard first-line platinum-based chemotherapy: EDEN trial
Titel:
An open-label, randomized phase III study of early switch maintenance vs delayed second-line nivolumab in advanced stage squamous non-small cell lung cancer (NSCLC) patients after standard first-line platinum-based chemotherapy: EDEN trial
Auteur:
Gelsomino, F. Tiseo, M. Boni, L. Cavanna, L. Camerini, A. Chiari, R. Verusio, C. Tognetto, M. Ardizzoni, A.